Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.52 |
| ▸ | FPR2 | P25090 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | ANPEP | P15144 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3376625 | 1.00 | SRC (0.52) | SRCFPR2LMNAMAPK1NAALAD2 | |
| SCHEMBL627377 | 1.00 | SRC (0.52) | SRCFPR2LMNAMAPK1NAALAD2 | |
| SCHEMBL5936861 | 0.98 | SRC (0.50) | SRCFPR2LMNAMAPK1NAALAD2 | |
| SCHEMBL14397406 | 0.88 | FPR2 (0.49) | SRCFPR2LMNAMAPK1NAALAD2 | |
| SCHEMBL5744468 | 0.88 | TACR3 (0.48) | SRCMTNR1AMTNR1BALDH1A1KMT2A | |
| SCHEMBL890060 | 0.88 | TACR3 (0.48) | SRCMTNR1AMTNR1BALDH1A1KMT2A | |
| SCHEMBL18610229 | 0.88 | TACR3 (0.48) | SRCMTNR1AMTNR1BALDH1A1KMT2A | |
| SCHEMBL6970828 | 0.86 | MTNR1A (0.46) | SRCMTNR1AMTNR1BALDH1A1KMT2A | |
| SCHEMBL9068474 | 0.85 | HPGD (0.49) | SRCFPR2LMNAMAPK1NAALAD2 | |
| SCHEMBL14339911 | 0.85 | HPGD (0.49) | SRCFPR2LMNAMAPK1NAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090036679-A1 | METHOD FOR RESOLVING ENANTIOMERS FROM RACEMIC MIXTURE HAVING CHIRAL CARBON IN ALPHA POSITION OF NITROGEN | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2009-02-05 | — | — | US | claimed |
| EP-1984358-A1 | METHOD FOR RESOLVING ENANTIOMERS FROM RACEMIC MIXTURE HAVING CHIRAL CARBON IN ALPHA POSITION OF NITROGEN | Chong Kun Dang Pharmaceutical Corp. (KR) | 2008-10-29 | — | — | EP | claimed |
| WO-2007091753-A1 | METHOD FOR RESOLVING ENANTIOMERS FROM RACEMIC MIXTURE HAVING CHIRAL CARBON IN ALPHA POSITION OF NITROGEN | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2007-08-16 | — | — | WO | claimed |
| US-20230257388-A1 | GRANZYME B DIRECTED IMAGING AND THERAPY | CYTOSITE BIOPHARMA INC. (US) | 2023-08-17 | — | — | US | disclosed |
| US-11667645-B2 | Granzyme B directed imaging and therapy | CYTOSITE BIOPHARMA INC. (US) | 2023-06-06 | — | — | US | disclosed |
| WO-2023078410-A1 | COMPOUND HAVING ACTIVITY OF DEGRADING GSPT1 AND APPLICATION THEREOF | 上海美志医药科技有限公司 | 2023-05-11 | — | — | WO | disclosed |
| US-20220266397-A1 | FLUX AND SOLDER PASTE | KOKI COMPANY LIMITED (JP) | 2022-08-25 | — | — | US | disclosed |
| WO-2021107686-A1 | EDARAVONE PRODRUG COMPOUND AND PHARMACEUTICAL USE THEREOF FOR TREATING OR ALLEVIATING NEURODEGENERATIVE OR MOTOR NEURON DISEASES | 제이투에이치바이오텍 주식회사 | 2021-06-03 | — | — | WO | disclosed |
| CN-112261939-A | Granzyme B directed imaging and therapy | 塞托赛特生物制药股份有限公司 | 2021-01-22 | — | — | CN | disclosed |
| US-20200369673-A1 | GRANZYME B DIRECTED IMAGING AND THERAPY | CYTOSITE BIOPHARMA INC. | 2020-11-26 | — | — | US | disclosed |
| US-20170340604-A1 | THERAPEUTIC COMPOUNDS AND USES THEREOF | GENENTECH, INC. (US) | 2017-11-30 | — | — | US | disclosed |
| US-7291627-B2 | Dihydroimidazo[5.1-a]-beta-carboline derivatives, method for their preparation, and their application as a drug | MACEF (FR) | 2007-11-06 | — | — | US | disclosed |
| WO-2007091753-A1 | METHOD FOR RESOLVING ENANTIOMERS FROM RACEMIC MIXTURE HAVING CHIRAL CARBON IN ALPHA POSITION OF NITROGEN | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2007-08-16 | — | — | WO | disclosed |
| US-7217794-B2 | Compounds and methods for treatment of thrombosis | DAIAMED, INC. (US) | 2007-05-15 | — | — | US | disclosed |
| US-20060089372-A1 | Dihydroimidazo[5,1-a]sg(b)-carboline derivatives, method for preparing same and use thereof as medicine | MACEF (FR) | 2006-04-27 | — | — | US | disclosed |
| US-5102667-A | Antiallergens, antiinflammatory agents, nervous system disorders, immunology, psychological disorders | RHONE-POULENC SANTE (FR) | 1992-04-07 | — | — | US | disclosed |
| EP-0163537-A1 | 1-Propanone derivatives and pharmaceutical compositions containing same | TOKYO TANABE COMPANY LIMITED (JP) | 1985-12-04 | — | — | EP | disclosed |
| US-4267174-A | AND PROCESS FOR ADMINISTERING | BOEHRINGER MANNHEIM, GMBH (DE) | 1981-05-12 | — | — | US | disclosed |
| US-4115439-A | Process for the preparation of optically active α-phenylglycine and intermediates thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1978-09-19 | — | — | US | disclosed |
| US-4107203-A | SEED CRYSTALS ADDED TO SOLUTION IN PRESENCE OF METAL CHLORIDE | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1978-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060089372-A1 | Dihydroimidazo[5,1-a]sg(b)-carboline derivatives, method for preparing same and use thereof as medicine | GDI2, GDI1, CYP2A7 | SRC 3213/4885FPR2 2038/4885LMNA 3198/4885 |
| US-20230257388-A1 | GRANZYME B DIRECTED IMAGING AND THERAPY | GZMB, PRF1, CTSB | SRC 3760/4885FPR2 452/4885LMNA 783/4885 |
| US-20200369673-A1 | GRANZYME B DIRECTED IMAGING AND THERAPY | GZMB, PRF1, CTSB | SRC 3760/4885FPR2 452/4885LMNA 783/4885 |
| US-20090036679-A1 | METHOD FOR RESOLVING ENANTIOMERS FROM RACEMIC MIXTURE HAVING CHIRAL CARBON IN ALPHA POSITION OF NITROGEN | SRR, NPEPPS, DNPEP | SRC 2827/4885FPR2 2895/4885LMNA 1837/4885 |
| US-11667645-B2 | Granzyme B directed imaging and therapy | GZMB, PRF1, CTSB | SRC 3760/4885FPR2 452/4885LMNA 783/4885 |
| US-20170340604-A1 | THERAPEUTIC COMPOUNDS AND USES THEREOF | BRD4, BRDT, BRD3 | SRC 569/4885FPR2 3084/4885LMNA 2473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.